American Diabetes Association, Lilly Announce New Scholars Program for 74th Annual Scientific Sessions

Alexandria, Virginia
January 29, 2014

The American Diabetes Association (Association) and Eli Lilly and Company are pleased to announce the creation of the American Diabetes Association Scholars Program.  The program, made possible through $1.1 million in support from Lilly, will provide scholarships for up to 100 scholars from outside the U.S. to attend this year’s Scientific Sessions, the world’s largest scientific and medical conference focused on diabetes and its complications.

“The American Diabetes Association is thrilled to join with Eli Lilly and Company to award the American Diabetes Association Scholars Program,” said Robert E. Ratner, MD, FACP, FACE, chief scientific & medical officer, American Diabetes Association. “Lilly’s support provides scientists from countries around the world that are seeing a significant increase in diabetes, the opportunity to attend this educational program and be trained in the clinical management of the disease. Then, they will be able to return to their home country and conduct these educational programs, furthering our fight to Stop Diabetes® across the globe.”

The Association’s 74th Annual Scientific Sessions, to be held in San Francisco June 13-17, brings together physicians, scientists and other health care professionals from around the world to learn about the latest advances in basic and clinical science for diabetes. Selected scholars will attend the program, as well as participate in a professional education program which will provide training and resources for scholars to serve as faculty for professional education programs when they return to their home countries.  The Association will provide reporting tools for scholars and track the presentation opportunities they undertake.

“Diabetes is a global epidemic, so it’s critical that clinicians and scientists across the world have access to the most recent information in order to appropriately treat and fight this disease,” said Robert Heine, vice president, medical affairs, Lilly Diabetes. “Lilly is pleased to provide support for the Association’s scholars program and looks forward to this year’s Scientific Sessions.”

Countries participating in the program include:

  • Algeria
  • Argentina
  • Brazil
  • China
  • Colombia
  • Egypt
  • Ghana
  • India
  • Indonesia
  • Kenya
  • Malaysia
  • Mexico
  • Morocco
  • Nigeria
  • Philippines
  • Singapore
  • South Africa
  • Taiwan
  • Thailand
  • Vietnam

 
Interested applicants should email adascholars@diabetes.org for more information.

To learn more about Lilly Diabetes, visit lillydiabetes.com.

About the American Diabetes Association

Nearly half of American adults have diabetes or prediabetes; more than 30 million adults and children have diabetes; and every 21 seconds, another individual is diagnosed with diabetes in the U.S. Founded in 1940, the American Diabetes Association (ADA) is the nation’s leading voluntary health organization whose mission is to prevent and cure diabetes, and to improve the lives of all people affected by diabetes. The ADA drives discovery by funding research to treat, manage and prevent all types of diabetes, as well as to search for cures; raises voice to the urgency of the diabetes epidemic; and works to safeguard policies and programs that protect people with diabetes. In addition, the ADA supports people living with diabetes, those at risk of developing diabetes, and the health care professionals who serve them through information and programs that can improve health outcomes and quality of life. For more information, please call the ADA at 1-800-DIABETES (1-800-342-2383) or visit diabetes.org. Information from both of these sources is available in English and Spanish. Find us on Facebook (American Diabetes Association), Twitter (@AmDiabetesAssn) and Instagram (@AmDiabetesAssn)